லில்லி ஆன்டிபாடி வெட்டுக்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The world has been fixated for months on novel-coronavirus PCR testing, contact tracing and vaccination.
Meanwhile, another major part of the Covid biomedical complex has received far less attention: the use of antibodies for detecting, diagnosing and treating infection with the novel coronavirus.
Hundreds of antibodies have been approved for these purposes since January 2020. And hundreds more are poised to start being marketed soon.
This is part of the biomedical gold rush: by last summer already, antibodies were on track to become the most lucrative medical product, with global revenue projected to reach nearly half a trillion dollars by 2024.
Profit margins in the range of ....

New York , United States , United Kingdom , British Columbia , South Africa , Columbia University , South African , Pratiek Matkar , Donald Trump , Bryan Jones , Daniel Skovronsky , Anthony Fauci , Gina Kolata , Eli Lilly , Zhen Lu , John Montalbano , David Rimm , Ian Lipkin , Patrick Corbett , Scott Adams , David Crowe , Cliffordb Saper , W Ian Lipkin , Clifford Saper , Peter Thiel , Lilly Biotechnology Research Program ,